Betulinic acid reduced penile smooth muscle apoptosis in nerve-injured rats, but this is a 5-rats-per-group rodent study with no funding disclosure
Journal: European Journal of Pharmacology | Published: 2026-05-12 | Type: Journal Article | PMID: 42114731 Authors: Xi Yuhang, Zhang Shaohua, Li Xiaojie, Zhang Xinjun, Xue Xiangdong, Hou Guodong, Zhu Feng (Department of Urology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China) Funding/COI: Funding not listed. Authors declare no competing financial interests.
Betulinic acid (BA), a pentacyclic triterpenoid derived from birch bark, was tested in a rat model of post-prostatectomy erectile dysfunction caused by cavernous nerve injury (CNI). In 20 Sprague-Dawley rats randomized to four groups (sham, bilateral CNI, low-dose BA, high-dose BA), both doses of BA improved electrically-stimulated erectile function and reduced cavernous tissue damage over four weeks. The proposed mechanism runs through the Nrf2/HO-1 antioxidant pathway, which BA activated in both live animals and hydrogen peroxide-stressed smooth muscle cells in culture.
This is a small, short-term preclinical study with five rats per group — at the absolute floor of what can support mechanistic conclusions. Four weeks of intragastric BA administration followed by a single erectile function assessment is a reasonable proof-of-concept design for this type of research, but the sample size provides essentially no statistical power to detect anything but large effect sizes. The in vitro arm (H2O2-induced apoptosis in CCSMCs) is a useful mechanistic complement, but hydrogen peroxide as an oxidative stressor is a blunt instrument that does not faithfully replicate the specific injury milieu of cavernous nerve crush.
Specific doses of BA are mentioned as "low" and "high" but the abstract does not report the actual mg/kg values, nor does it provide effect sizes or p-values for the primary erectile function outcome. Without these numbers, the claim that BA "improved" erectile function is unverifiable from this abstract alone.
This is early-stage preclinical signal generation, not evidence of a treatment. Five rats per group is too small to draw reliable conclusions, the funding source is unknown, and the leap from "H2O2-stressed rat smooth muscle cells respond to a birch bark compound" to "this helps men after prostate surgery" crosses several unbridged gaps. The Nrf2/HO-1 mechanism is worth knowing about if you follow antioxidant pathways in post-prostatectomy ED research, but this paper contributes a weak data point at the bottom of the evidence pyramid. File it under "mechanistic hypothesis, needs replication at 10x the sample size in a funded, pre-registered trial."